I spent the day on Tuesday at the Delivering Alpha conference, which is hosted by CNBC and Institutional Investor — it’s not the kind of confab that includes “secret” or special ideas that you can’t hear about elsewhere (it’s hosted by CNBC, after all, and they broadcast from the conference all day), but it’s an […]
Articles
- Most Relevant
- Most Recent
There’s been a lot going on among the stocks that I own and those that I’ve written a lot about for you over the years, so I have a bit of updating to share when it comes to my thoughts … first, some thoughts on two large personal holdings that I’ve never suggested in the […]
It’s been an unusually active month in the Real Money Portfolio — a couple big sells, several brand new positions, and quite a bit more churn than I usually have. Those transactions have mostly been fairly small, the largest position that I opened or closed was the sale of my sub-2% Facebook position, but that’s […]
Michael Robinson this week is pitching his Nova-X Report with a promise that “we’re about to witness one of the most massive rollouts in history” as a new “magic electricity” ends the days of wires and plugs and dead batteries and makes us all filthy, stinkin’ rich. So what the heck is he talking about? […]
A few relatively brief things for you today — updates on the flailing ICON and the high-yield MPW, and a few thoughts on “macro” panics in the market. First, the ugly — checking in on Iconix (ICON), which I last looked at a few months ago. The stock has gotten cut in half just since […]
This is a teaser that many of you have already figured it out, but I’m still seeing it in heavy rotation so I thought I’d share … it’s from an ad for Karim Rahemtulla’s Xcelerated Profits Report, I don’t think we’ve looked at his stuff since their fabulous ad for “Dark Equities” a few months […]
Dr. David Eifrig is one of the Stansberry writer/editors, and for a couple of years now he has put out the Retirement Millionaire newsletter that seems to be largely focused on ways to get special perqs and discounts as a retireee … as well as a bit of financial commentary and ideas, I’m told (I […]
OK, I’ll cut right to the core point: The US economy is going to boom so aggressively over the next few years that whoever will be president is going to get re-elected, even if it means amending the constitution to ensure we get to keep Obama in office. So that’s the premise — the pitch […]
Yesterday we dug into the teaser pitch for Blue Chip Gems that promised Bret Jensen’s “#1 Forever Stock for 2016,” and I told you I’d try to also name his other two picks… … so that’s today’s goal, identifying those other two members of Jensen’s “Top 3 Buy and Hold ‘Forever Stocks’” portfolio. We don’t […]
Kevin Massengill has recently been pushing his Defense Technology Alert by dropping some hints about his two favorite investments… including what he says is “My Top Defense Play of All Time.” So what’s the story? Well, you could subscribe to find out, I suppose, if you feel like ponying up $2,000 a year and trust […]
Yesterday we started looking at Byron King’s recent teaser for a graphite/graphene company, part of his new ad campaign for Energy and Scarcity Investor that hypes three “miracle materials” that have the potential to change the world … and today, as promised, we’re staying on this track and getting to his second pick, some sort […]
UNLOCKED: PRIVATE DEALS THAT MINT MILLIONAIRESAugust 15, 2014 Dear Reader, Right now, a unique life-saving effort is underway in a sub-niche of the financial markets. If you choose to invest in this ”campaign” – as I’ll outline in a moment – your reward will be twofold… First, you’ll get the deep satisfaction of knowing your investment helped save lives – […]
Investment advisory focusing on technology trends, they say they’re looking for “growth and income from the utility stocks of the future.”
Each year I check in on every company that I own and cover for the Irregulars, even those where my opinion doesn’t change much from month to month (or even from year to year, in some cases)… but we’re going to do it a little differently this year. This is all part of what will […]
Today I continue my annual navel-gazing for you, as I look at each position in my portfolio — though this year, as I mentioned in our kickoff last week, I’m changing the way I describe, report and follow these stocks for you, largely so that I can be clearer about my preferences and opinions and […]
This is the third time I’ve bought an IPO on its first day of trading, and the second time I’ve bought exposure to a SPAC over the past year — hopefully it will work out as well as the others. I saw Chamath Palihapitiya speak at the Delivering Alpha conference on Tuesday, along with Starwood’s […]
I’m still able to generate some enthusiasm about specific stocks that I think are appealing enough to buy at these prices… but I find it very hard to be optimistic in a macro sense right now, it really feels to me as though the market is whistling past the graveyard and being far too sanguine […]
Things are starting to heat up in earnings season, and the big takeaway for me so far, with Alphabet reporting yesterday, is more confirmation that mobile advertising is making some fortunes for shareholders — so today I’ll check in with Google/Alphabet, add some thoughts about Facebook and Twitter (which have yet to report), and update […]
[Ed. Note: Dr. KSS writes for the Irregulars about medicine and biotech stocks. He has agreed to our trading restrictions, chooses his own topics, and his words and opinions are his own. Enjoy!] Readers not familiar with Stock Gumshoe usually arrive wondering if the salivation provoked by stock promotional writers for certain companies is justified. […]
Another Motley Fool growth stock to sniff out for you today … David Gardner has gotten a reputation as a compelling “rule breaking” growth stock picker over the past few decades, with some huge winners chosen (and held through very tumultuous times) as he built the Motley Fool with his brother Tom. The flagship Motley […]
Hello fellow Gumshoers! In keeping with the Gumshoe process of performing due diligence for investing, I would like to share my results of a visit to Junior mining Home offices I recently visited. I work for Chevron Oil, and had the good fortune to visit beautiful Vancouver, British Columbia. Staying in downtown Vancouver afforded me […]
August 15, 2014 Dear Reader, Right now, a unique life-saving effort is underway in a sub-niche of the financial markets. If you choose to invest in this ”campaign” – as I’ll outline in a moment – your reward will be twofold… First, you’ll get the deep satisfaction of knowing your investment helped save lives – […]
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. His words and opinions are his own.] In A History of New York, Washington Irving opens chapter VIII thus: ”In which the author and reader…fall into a very grave and instructive discourse.” This may prove to be a more unleavened column than […]
[Ed. Note: Dr. KSS writes about biotech stocks for the Irregulars. We have not reviewed or approved his topics or opinions, and he has agreed to our trade restrictions. Enjoy!] Twenty years ago, I was living life on an extreme slant as a medicine resident. My routine was a rut of working 36 hours, having […]
“An opportunity this good only comes along once twice in a lifetime. “These 3 quick-action interviews with our Foolish investing experts (below) show how to prepare yourself for the $19 trillion revolution that’s swallowing up the Internet. And how to zero in on the 3 next-generation technology stocks that are best positioned to profit. “I’m […]
[Ed. Note: Here is the latest from Dr. KSS, who writes about health, medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his words and ideas are his own.] Dedicated to Cynthia Chew Choon Hoon (1959-2013). In pace requiescat. Imagine a day down the hallway of the future. You’re […]
[Ed. Note: Dr. KSS, formerly knowns as karmaswimswami on our discussion threads, is here again to talk to the Irregulars about health and medicine and biotech investing ideas. As with all of our guest contributors, he has agreed to our trading restrictions and we have not reviewed, approved or screened his stocks or ideas, and […]
Another Monday morning, another “next wave of the internet” teaser. This teaser comes in from the Oxford Income Letter, edited by Marc Lichtenfeld over at the Oxford Club, and it’s a bit of a departure from the crazy small cap names he has more often touted of late (usually for his MicroCap Tech Trader newsletter). […]
[Ed. Note: Here is our second installment from Dr. KSS, formerly known as “karmaswimswami” in Gumshoe discussion threads. Dr. KSS has agreed to our trading and disclosure restrictions, and he’s not offering you personal investment or medical advice. As with all of our columnists, we don’t assign topics or opinions and do just a bit of light […]
The US certainly doesn’t have a monopoly on tech startups, or on breakthrough ideas, or even on dreams of avarice … so I guess it should come as no surprise that we also do not have a monopoly on breathlessly-hyped breakthrough technology newsletters. This latest one that I first heard about quite recently is from […]
“What tangled webs we mortals weave when first we practice to deceive” – Shakespeare “There’s a sucker born every minute” – P.T. Barnum I know its been only a few days since my March article ran on these cyber-pages, but there is an issue currently unfolding in the market that simply may not wait until […]
Anyone familiar with Leo? I think this is new pub. From Investing Daily, which gives me pause.
The Motley Fool gets more coverage here at Stock Gumshoe than pretty much any other newsletter publisher, with the possible exception of Stansberry — partly because the Fool has had some very good picks over the years, and partly because they have one of the biggest email lists around and they push a lot of […]
Another Motley Fool growth stock to sniff out for you today … David Gardner has gotten a reputation as a compelling “rule breaking” growth stock picker over the past few decades, with some huge winners chosen (and held through very tumultuous times) as he built the Motley Fool with his brother Tom. The flagship Motley […]
David Gardner has touted and teased many stocks for both his Rule Breakers and his Stock Advisor services — probably, in fact, we’ve covered more Motley Fool teaser ads here at Stock Gumshoe than we have any other publisher (and according to the quick calculations of one of our readers, they’ve had more winners than […]
Carl Chen presented about Taiwan and China, presenting a Taiwanese stock and a Chinese stock. They think that China is still on the ascendancy, and that it has become too fashionable to talk about the failure of China, which has the longest existing human culture on the planet. Taiwan is a great place to look […]
The guys from COMPOUND Capital presented at the last Congress too, and they have had some interesting ideas — they have two stocks to share today. They look for recurring revenue, owner operators, balance sheet slack and limited leverage, undervalued companies or confusing situations. They like names that don’t screen well and have limited analyst […]
OK, OK, the questions on this one are getting a bit overwhelming — and I’m afraid that if I don’t cover this one soon the villagers will soon be gathering their fiery torches and marching on Castle Gumshoe … so here goes. Louis Basenese and the folks at Wall Street Daily are pitching his MicroCap […]
As I typically do after attending the Value Investing Congress, I’m selecting one of my favorite ideas from the conference to share with you as our next “Idea of the Month.” The selection process was a little tough this time, because there were several picks that I found pretty compelling — a couple specialty insurance […]
Ian Wyatt is out with a new teaser promo for his $100K Portfolio service, and it’s all about a young company that’s growing rapidly and changing America in a substantial way … with a free new “highway” across the country. He pitches this secret stock using the same kind of language that several other growth-focused […]
Recent Comments
Hi everyone, I am a part time model with a business degree. Over the last 2 years i've had alot of financial success with modelling and wanted to do some…...
Dear Dr. KSS, Every day has been like Christmas on SG because of your giving the gift of yourself - your time, boundless medical, biochemical, biotech, and pharmaceutical knowledge, smart…...
The most important Biblical financial principle is tithing; if I don't trust God enough to give back that 10% (which is His anyway), how can I expect Him to bless…...
How about this one? his Election Day Shocker Could Fund Your Retirement By Sandy Franks, Executive Director, Smart Investing Daily Dear Reader, Forget Romney and Obama... I'm writing to you…...
Shoeman has anyone done anything on currency x which is a secret account that is set aside for all us to draw from? Its touted by The League of Power…...
I'm waiting to hear from Stock Gumshoe on this one, please! As always, the pitch on this one is fear driven, based on some true things and some embelleshment along…...